These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29565821)

  • 1. Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses.
    Saito MM; Ejima K; Kinoshita R; Nishiura H
    Int J Environ Res Public Health; 2018 Mar; 15(4):. PubMed ID: 29565821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling a Supplementary Vaccination Program of Rubella Using the 2012⁻2013 Epidemic Data in Japan.
    Kayano T; Lee H; Nishiura H
    Int J Environ Res Public Health; 2019 Apr; 16(8):. PubMed ID: 31027277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008.
    Castillo-Solórzano C; Reef SE; Morice A; Vascones N; Chevez AE; Castalia-Soares R; Torres C; Vizzotti C; Ruiz Matus C
    J Infect Dis; 2011 Sep; 204 Suppl 2():S713-7. PubMed ID: 21954271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination.
    Metcalf CJ; Lessler J; Klepac P; Cutts F; Grenfell BT
    Epidemiol Infect; 2012 Dec; 140(12):2290-301. PubMed ID: 22335852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain.
    Vilajeliu A; García-Basteiro AL; Valencia S; Barreales S; Oliveras L; Calvente V; Goncé A; Bayas JM
    Vaccine; 2015 Apr; 33(15):1767-72. PubMed ID: 25731790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economics of rubella: a systematic review to assess the value of rubella vaccination.
    Babigumira JB; Morgan I; Levin A
    BMC Public Health; 2013 Apr; 13():406. PubMed ID: 23627715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of rubella vaccine policy for the UK.
    Knox EG
    Int J Epidemiol; 1987 Dec; 16(4):569-78. PubMed ID: 3440667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
    Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.
    Khanal S; Bahl S; Sharifuzzaman M; Dhongde D; Pattamadilok S; Reef S; Morales M; Dabbagh A; Kretsinger K; Patel M
    MMWR Morb Mortal Wkly Rep; 2018 Jun; 67(21):602-606. PubMed ID: 29851943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from epidemiological game theory into gender-specific vaccination against rubella.
    Shim E; Kochin B; Galvani A
    Math Biosci Eng; 2009 Oct; 6(4):839-54. PubMed ID: 19835431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009.
    Reef SE; Strebel P; Dabbagh A; Gacic-Dobo M; Cochi S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S24-7. PubMed ID: 21666168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing herd immunity against rubella in Japan: a retrospective seroepidemiological analysis of age-dependent transmission dynamics.
    Kinoshita R; Nishiura H
    BMJ Open; 2016 Jan; 6(1):e009928. PubMed ID: 26817640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of rubella vaccine administered to pregnant women: A systematic review of pregnancy related adverse events following immunisation, including congenital rubella syndrome and congenital rubella infection in the foetus or infant.
    Mangtani P; Evans SJW; Lange B; Oberle D; Smith J; Drechsel-Baeuerle U; Keller-Stanislawski B
    Vaccine; 2020 Jan; 38(5):963-978. PubMed ID: 31839467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policies for immunization against rubella in European countries.
    De la Mata I; De Wals P
    Eur J Epidemiol; 1988 Jun; 4(2):175-80. PubMed ID: 3402576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulations of rubella vaccination strategies in China.
    Gao L; Hethcote H
    Math Biosci; 2006 Aug; 202(2):371-85. PubMed ID: 16603207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella vaccination in India: identifying broad consequences of vaccine introduction and key knowledge gaps.
    Winter AK; Pramanik S; Lessler J; Ferrari M; Grenfell BT; Metcalf CJE
    Epidemiol Infect; 2018 Jan; 146(1):65-77. PubMed ID: 29198212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward elimination of rubella and congenital rubella syndrome--the Americas, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1176-9. PubMed ID: 18971920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
    Chang C; Mo X; Hu P; Liang W; Ma H; An Z; Liu J; Zheng H
    Vaccine; 2015 Jun; 33(28):3223-7. PubMed ID: 25989448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination.
    Wesolowski A; Mensah K; Brook CE; Andrianjafimasy M; Winter A; Buckee CO; Razafindratsimandresy R; Tatem AJ; Heraud JM; Metcalf CJ
    J R Soc Interface; 2016 Apr; 13(117):. PubMed ID: 27122178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit-cost aspects of rubella immunization.
    Schoenbaum SC
    Rev Infect Dis; 1985; 7 Suppl 1():S210-1. PubMed ID: 3923595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.